| 10.04 -2.13 (-17.5%) | 08-07 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 18.9 | 1-year : | 28.82 |
| Resists | First : | 16.18 | Second : | 24.68 |
| Pivot price | 6.23 |
|||
| Supports | First : | 2.44 | Second : | 2.03 |
| MAs | MA(5) : | 11.49 |
MA(20) : | 5.94 |
| MA(100) : | 7.48 |
MA(250) : | 13.11 |
|
| MACD | MACD : | 1.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 40.4 |
D(3) : | 47.8 |
| RSI | RSI(14): 56.4 |
|||
| 52-week | High : | 32.54 | Low : | 2.44 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AMIX ] has closed below upper band by 30.0%. Bollinger Bands are 550% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 14.23 - 14.3 | 14.3 - 14.36 |
| Low: | 10.37 - 10.43 | 10.43 - 10.48 |
| Close: | 12.06 - 12.17 | 12.17 - 12.26 |
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Wed, 05 Aug 2026
Autonomix Medical, Inc. (AMIX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Wed, 05 Aug 2026
AMIX Stock Rockets On Resale News As Dilution Risks Build - StocksToTrade
Wed, 05 Aug 2026
AMIX Stock Rockets As Cash Deals Collide With Dilution Fears - StocksToTrade
Wed, 05 Aug 2026
Autonomix Medical, Inc. SEC Filing (Aug 5, 2026) - Stock Titan
Wed, 05 Aug 2026
Autonomix Medical Soars 434% as Patent Filings Indicate 2025 Grant - The Wall Street Journal - TechStock²
Tue, 04 Aug 2026
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 4.1 (%) |
| Held by Institutions | 4.2 (%) |
| Shares Short | 62 (K) |
| Shares Short P.Month | 16 (K) |
| EPS | -48.73 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.85 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -122.4 % |
| Return on Equity (ttm) | -238.9 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -31.35 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.21 |
| PEG Ratio | 0 |
| Price to Book value | 0.92 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.45 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|